Yinuoke
October 17, 2023
Franciscan C
Oncology
Company Description: Yinuoke is a biotech company developing First-in-Concept therapies for cancer patients who have exhausted available therapies based on a deep and unique understanding of cancer biology and immunology. We are developing a pipeline with multiple innovative therapeutic products aiming to reshape the care of terminal cancer.
Speakers
Country
China
Website
http://under development
CEO/Top Company Official
CEO
Lead Product in Development
YNK105: small molecule drug for cancer cachexia; IND-enabling
YH101: FIC antibody drug for cancer and cancer cachexia: IND-enabling
Development Phase of Primary Product
Pre-Clinical
Number Of Unlicensed Products
2